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Abstract
Background: Gastro-oesophageal reflux disease (GORD) symptoms are common in asthma and have been
extensively studied, but less so in the Asian continent. Reflux-associated respiratory symptoms (RARS) have, in
contrast, been little-studied globally. We report the prevalence of GORD symptoms and RARS in adult asthmatics,
and their association with asthma severity and medication use.
Methods: A cross-sectional analytical study. A validated interviewer-administered GORD scale was used to assess
frequency and severity of seven GORD symptoms. Subjects were consecutive asthmatics attending medical clinics.
Controls were matched subjects without respiratory symptoms.
Results: The mean (SD) composite GORD symptom score of asthmatics was significantly higher than controls (21.8
(17.2) versus 12.0 (7.6); P < 0.001) as was frequency of each symptom and RARS. Prevalence of GORD symptoms in
asthmatics was 59.4% (95% CI, 59.1%-59.6%) versus 28.5% in controls (95% CI, 29.0% - 29.4%). 36% of asthmatics
experienced respiratory symptoms in association with both typical and atypical GORD symptoms, compared to
10% of controls (P < 0.001). An asthmatic had a 3.5 times higher risk of experiencing a GORD symptom after
adjusting for confounders (OR 3.5; 95% CI 2.5-5.3). Severity of asthma had a strong dose-response relationship with
GORD symptoms. Asthma medication use did not significantly influence the presence of GORD symptoms.
Conclusions: GORD symptoms and RARS were more prevalent in a cohort of Sri Lankan adult asthmatics
compared to non-asthmatics. Increased prevalence of RARS is associated with both typical and atypical symptoms
of GORD. Asthma disease and its severity, but not asthma medication, appear to influence presence of GORD
symptoms.
Background
Gastro-oesophageal reflux disease (GORD) symptoms
are common in asthmatics. A recent systematic review
on GORD symptom assessment in asthmatics reported
an estimated prevalence ranging from 30-90% com-
pared to 10-20% in the general population [1]. A study
from South East Asia reported a GORD symptom pre-
valence of 57% in asthmatics compared to 34% in non-
asthmatic controls [2], and a study of an urban Indian
population found that 74.8% of asthmatics had a his-
tory of GORD [3]. There is also evidence that the
severity and frequency of GORD symptoms are related
t ot h es e v e r i t yo fa s t h m a[ 4 - 6 ] .I n d i v i d u a la s t h m a
drugs have also been shown to predispose towards
GORD [7-11]. In addition to a higher prevalence of
GORD symptoms, asthmatics also associate GORD
symptoms with respiratory symptoms, the so-called
Reflux Associated Respiratory Symptoms (RARS). Sev-
eral studies report chronic respiratory manifestations
of GORD [12-14]. Others report an association
between reflux and cough [15,16] and reflux and bron-
chial hyperresponsiveness [17-19]. However few studies
have investigated whether asthmatics experience
respiratory symptoms at the time of GORD symptoms
[20,21] and none from the Asian continent.
In this study, we investigated the prevalence of GORD
symptoms and RARS in a population of adult asthmatics
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ciation of asthma severity and asthma medication use
with the presence of GORD symptoms.
Methods
A cross-sectional analytical survey was carried out pro-
spectively at the Colombo North Teaching hospital in
Sri Lanka over a two year period. Ethical approval was
obtained from the Scientific and Ethics Review Commit-
tee of the Faculty of Medicine, University of Kelaniya.
Adult asthmatics and matched non-asthmatics between
the ages of 15-60 years were recruited from medical
clinics in the hospital. Those who had previous oesopha-
geal or gastric disease other than GORD, had undergone
previous upper gastro-intestinal surgery or had known
diabetes mellitus were excluded. All subjects gave
informed written consent before the study.
Consecutive asthmatics either newly diagnosed or in
follow-up, were recruited according to American Thor-
acic Society guidelines for the definition of asthma [22].
Controls were either clinic attendees, those accompany-
ing them or hospital staff who did not have respiratory
symptoms, asthma or other respiratory illness.
Study protocol
Diagnosis of asthma
Subjects were asked five questions to assess presence or
absence of asthma symptoms, in relation to a recall per-
iod of 12 months preceding the interview [23].
(1) Have you at any time had wheezing or whistling
in your chest?
(2) Have you at any time been breathless when you
had wheezing or whistling in your chest?
(3) Have you at any time been woken up with a feel-
ing of tightness in your chest?
(4) Have you at any time been woken up by an
attack of coughing?
(5) Have you at any time been woken up by an
attack of shortness of breath?
Those with a positive response to one or more ques-
tions underwent a white cell and differential count exam-
ination and a plain chest radiograph. In those with
absolute eosinophilia, the Wuchereria bancrofti antigen
test (NOW® Filariasis, rapidI C T ,B i n a x ,S c a r b o r o u g h ,
USA) and examination of stools for helminth ova using
the direct smear method [24] were done to exclude alter-
native diagnoses (tropical pulmonary eosinophilia, Loef-
fler’s syndrome). Spirometry was performed using a
portable hand-held spirometer (Micro Plus spirometer,
Micro Medical Limited, Rochester, UK). Forced Vital
Capacity (FVC), Forced Expired Volume in the first sec-
ond (FEV1), Peak Expiratory Flow Rate (PEFR) were
recorded after each of three consecutive forced expiratory
efforts, both pre and post bronchodilator administration
(15 minutes after inhalation of 400 μg of salbutamol from
a metered dose inhaler via a valved spacer). A 12%
improvement and 200 mL increase in FEV1 following
bronchodilator administration was considered diagnostic
of asthma. Predicted values for Sri Lankans were derived
from data of Udupihille et al. [25]. Body mass index
(BMI) was calculated for each subject.
Assessment of GORD symptoms
All asthmatics and controls were interviewed by the
same investigator using a previously validated GORD
scale that assessed the frequency and severity of seven
symptoms of reflux disease (table 1) using a recall per-
iod of the past 4 weeks. For each symptom the patient
was asked two questions: “how often do you have this
problem?” to assess frequency, and “how much does this
problem bother you?” to assess severity. The frequency
and severity were scored on a Likert scale (table 1). The
subjects were given a cue card from which they chose
the relevant response. A composite symptom score was
calculated as the sum of products of symptom frequency
and severity of each symptom. This resulted in scores
from 1 to 20 for each symptom, with a total maximum
score of 140 and a minimum score of 7. A subject was
categorized as GORD symptom positive if the composite
Table 1 Wording of description of gastro-oesophageal
reflux disease (GORD) symptoms
Symptom* Description
Heartburn Burning pain in chest or abdomen
Regurgitation Episodes of bitter or sour fluid or food coming back
to your mouth
Abdominal/
chest pain
Upper abdominal pain or chest pain other than the
burning pain in the chest or abdomen
Abdominal
distension
Feeling of fullness in your upper abdomen
Dysphagia Difficulty in swallowing
Cough Episodes of cough during the day following a meal
or at night or when you wake up
Belching Episodes of wind coming up into your mouth
*Each symptom was asked in relation to meals using a 5-point Likert scale for
frequency and a 4-point Likert scale for severity.
e.g. for heartburn.
Do you have any episodes of burning pain in the chest or abdomen?
1 no.
2 once a month.
3 two to three times a week.
4 once a week.
5 daily.
How much does this problem bother you?
1 not at all.
2 mild discomfort, yet does not interfere with day-to-day activities.
3 moderate discomfort, interferes with day-to-day activities at least once a
week.
4 severe discomfort, interferes with day-to-day activities and sleep more than
once a week.
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Page 2 of 8GORD score cut-off ≥ was 12.5 and as GORD symptom
negative if the cut-off was <12.5. A subject categorized
as GORD symptom negative experienced either infre-
quent or no symptoms [26].
Assessment of reflux-associated respiratory symptoms
The presence or absence of cough, shortness of breath,
wheeze, and use of reliever medication at the time of
experiencing each of the seven GORD symptoms was
recorded (table 2).
Further questions were also included on smoking and
alcohol habit (whether they were current or past users
or had never used), on current asthma medication and
duration of use. They were specifically asked whether
they were taking oral salbutamol, inhaled salbutamol,
oral theophylline, oral steroids and inhaled steroids as
these drugs are known to induce GOR.
Statistical analysis
Sample size estimates were made using EpiInfo (EpiInfo
6, version 6.04 (1996), Centres of Disease Control and
Prevention, Atlanta, Georgia, USA and World Health
Organization, Geneva, Switzerland) and other statistical
analyses by SPSS for Windows (version 10, SPSS Inc.,
Chicago, Illinois, USA). Descriptive statistics are
reported as mean and SD. Differences between groups
were compared by the student t-test. Association
between categorical variables was tested using Fisher
Exact Test. Symptom prevalence between asthma and
control groups was compared using Pearson Chi Square
test. P values of less than 0.05 were considered signifi-
cant. Cross sectional associations between GORD symp-
tom status and whether asthmatic or not was analyzed
by logistic regression analysis where GORD symptom
status served as the dependent variable. Analysis was
adjusted for known confounders, namely age (categor-
ized into 10 year intervals), gender, BMI (categorized as
<25 kg/m
2 and ≥ 25 kg/m
2), smoking (categorized as
never smoked or ever smoked) and alcohol habits (cate-
gorized as never drank or ever drank). In the asthmatic
population, logistic regression was used to examine the
relationship between asthma severity and presence of
GORD symptoms. The analysis was adjusted for the
known confounders and also for types of asthma medi-
cation whose use was found to be significantly asso-
ciated with GORD symptoms on univariate analysis.
Odds ratios (OR) and 95% confidence intervals (95% CI)
are reported for all logistic regression analyses.
Results
Two hundred and two asthmatics and 202 controls
completed the study. They were comparable in age and
sex. Demographic data of the subjects is given in tables
3 and 4.
Prevalence of GOR symptoms
The mean (SD) composite GORD score of asthmatics
was significantly higher than that of controls (21.8 (17.2)
versus 12.0 (7.6); P < 0.001 Mann Whitney U test). The
frequency distribution of each symptom was found to
be higher in asthmatics compared to controls (Figure 1).
Table 2 Presence of reflux-associated respiratory
symptoms
Please answer the following questions:
￿ When you experience this burning pain in the chest or abdomen:
1 Do you get a cough?
2 Do you get a wheeze?
3 Do you get increased shortness of breath?
4 Do you get chest tightness?
5 Do you need to use your inhaler?
￿ When you experience these episodes of bitter or sour fluid or food
coming back to your mouth:
1 Do you get a cough?
2 Do you get a wheeze?
3 Do you get increased shortness of breath?
4 Do you get chest tightness?
5 Do you need to use your inhaler?
￿ When you experience any other type of upper abdominal pain or
chest pain other than the burning pain in the chest or abdomen:
1 Do you get a cough?
2 Do you get a wheeze?
3 Do you get increased shortness of breath?
4 Do you get chest tightness?
5 Do you need to use your inhaler?
￿ When you experience fullness in your upper abdomen :
1 Do you get a cough?
2 Do you get a wheeze?
3 Do you get increased shortness of breath?
4 Do you get chest tightness?
5 Do you need to use your inhaler?
￿ When you experience difficulty in swallowing:
1 Do you get a cough?
2 Do you get a wheeze?
3 Do you get increased shortness of breath?
4 Do you get chest tightness?
5 Do you need to use your inhaler?
￿ When you experience air coming up into your mouth [belching], after
meals or not associated with meals:
1 Do you get a cough?
2 Do you get a wheeze?
3 Do you get increased shortness of breath?
4 Do you get chest tightness?
5 Do you need to use your inhaler?
Table 3 Demographic variables of subjects
Control
(n = 202)
Asthmatic
(n = 202)
P value
Age, yrs mean (SD) 32.8 (10.2) 34.9 (11.6) 0.057*
Males, no (%) 86 (44%) 89 (44%) 0.841
†
BMI, kg/m
2 mean (SD) 22.8 (2.84) 22.1 (3.03) 0.020*
Current smokers (%) 3.4 12.4 0.001
‡
Current drinkers (%) 7.9 14.8 <0.001
‡
*student t-test
†Fisher exact test
‡Chi squared test.
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Page 3 of 8Using a cut-off of >12.5, the prevalence of symptomatic
GORD in asthmatics was significantly higher than that
of the controls (59.4% [95% CI, 59.1%-59.6%] versus
28.5% [95% CI, 29.0% - 29.4%]; P < 0.001).
Associations between asthma and GORD symptom status
Asthmatics had a higher risk of being GORD symptom
positive (score of >12.5) (OR, 3.5 [95% CI, 2.5-5.3]) and
this association remained after adjustment for known con-
founders, namely age, gender, body mass index (BMI),
alcohol and smoking status (OR, 3.7 [95% CI, 2.4 - 5.8]).
Reflux-associated respiratory symptoms (RARS)
The total number of RARS was higher in asthmatics
compared to non-asthmatics with GORD symptom
scores > 12.5 (80% versus 20%, P < 0.05, z test) and also
Table 4 Demographic details of asthma patients
Asthmatics with GORD score
> 12.5 (n = 120)
Asthmatics with GORD score
<12.5 (n = 82)
P value
Age, yrs; mean (SD) 34.4 (11.4) 35.6 (11.8) 0.318
Males/females 53/67 36/46 1.000
BMI, kg/m
2; mean (SD) 21.9 (3.3) 22.6 (2.5) 0.126
Current smoker (% of subjects) 13.3 11.0 0.630
Current drinker (% of subjects) 20.0 7.3 0.040*
Asthma severity (% of subjects)
Mild intermittent 66.7 89.0 0.001
Mild persistent 22.5 9.8
Moderate or severe persistent 10.8 1.2
Asthma medication (% of subjects)
Oral salbutamol 68.3 50.0 0.009*
Inhaled salbutamol 53.3 62.2 0.212
Oral theophylline 33.3 28.0 0.426
Oral steroids 18.3 9.8 0.092
Inhaled steroids 40.0 34.1 0.399
*Chi squared test
% of subjects
P=0.004
P=0.022 P=0.020
P=0.017
P=0.021
P=0.028
Symptoms
Figure 1 Comparison of daily symptom frequencies in asthmatics versus controls; All comparisons using z test for comparison of
proportions.
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Page 4 of 8in asthmatics with GORD symptom scores > 12.5 com-
pared to those with GORD symptom scores <12.5 (96%
versus 4%, P < 0.05, z test). The commonest symptom
was reflux - associated difficulty in breathing. Table 5
shows the distribution of RARS.
Association of asthma severity and asthma medication
use with GORD symptom status
One hundred and twenty asthmatics (59.4%) had a
GORD symptom score >12.5 and 36% of all asthmatics
experienced one or more RARS. They differed signifi-
cantly from those with GORD symptom scores < 12.5
with respect to alcohol consumption, asthma severity
and use of oral salbutamol but were comparable in age,
gender, BMI and spirometry (Table 5). After adjusting
for the five known confounding variables, multivariate
analysis showed that asthma severity showed a signifi-
cant dose-response association with reflux symptoms
(P value for trend = 0.007). When compared to patients
with mild intermittent asthma, those with mild persis-
tent asthma had a higher risk (OR 2.8 (95% CI 1.1-7.0)
and those with moderate or severe asthma had a much
higher risk (OR 11.8 (95% CI 1.5-92.9) of being GORD
symptom positive (Additional file 1, Table S1).
Discussion
Estimates of the prevalence of GORD symptoms among
adult asthmatics vary widely. The pooled sample-size
weighted average prevalence of GORD symptoms in asth-
matics reported in a review using data from seven cross-
sectional questionnaire-based surveys was 59.2% [1].
Other individual studies have reported prevalences of
45% [2], 69.2% [6], 50% [27], 49.4% [28], 71% [29], 52.2%
[30], and 51% [31]. A more limited number of studies are
available from South East Asia. A prevalence of 57% in
asthmatics compared to 34.1% in non-asthmatic controls
has been reported from Thailand [2] and 74.8% from
India [3]. Hence the prevalence of GORD symptoms
seems to be similar within the South East Asian region
and similar to that outside the region too. All these stu-
dies have been conducted in asthma clinics at secondary
care hospitals in more urban settings [1]. As such our
findings are directly comparable.
We defined GORD symptom status by use of a pre-
viously determined cut-off point on a GORD score con-
structed using a validated and reproducible questionnaire
[26]. This composite score of GORD symptom frequency
and severity has been demonstrated to have good correla-
tion with 24 hour pH monitoring variables. We found that
the mean composite GORD score was positive in 59.4% of
asthmatics compared to 28.5% in non-asthmatics.
Typical symptoms such as heartburn and regurgita-
tion are commoner than atypical symptoms in GORD
patients [32,33]. From the present study, we found this
to be true in our population of asthmatics. The third
most frequent symptom was belching. We could not
f i n da n yp r e v i o u sd a t ao np r e v a l e n c eo fb e l c h i n go r
any other atypical symptom (chest pain or upper
abdominal pain, abdominal distension, dysphagia)
among asthmatics.
Table 5 Frequency distribution of individual Reflux-
Associated Respiratory Symptoms (RARS) in subjects
RARS Asthmatics with GORD
score
> 12.5 (n = 120)
Asthmatics with GORD
score
< 12.5 (n = 82)
Heartburn associated
cough 3 (2.5) 1 (1.2)
wheeze 4 (3.3) -
difficulty in
breathing
50 (41.7) -
chest tightness 4 (3.3) -
inhaler use 1 (0.8) -
Regurgitation associated
cough 2 (1.7) 1 (1.2)
wheeze 7 (5.8) -
difficulty in
breathing
29 (24.2) -
chest tightness 2 (1.7) -
inhaler use 3 (2.5) -
Abdominal/chest pain associated
cough 2 (1.7) -
wheeze 2 (1.7) -
difficulty in
breathing
20 (16.7) 1 (1.2)
chest tightness 7 (5.8) -
inhaler use 2 (1.7) -
Abdominal distension associated
cough 1 (0.8) -
wheeze 3 (2.5) 1 (1.2)
difficulty in
breathing
16 (13.3) 2 (2.4)
chest tightness 7 (5.8) -
inhaler use 3 (2.5) 1 (1.2)
Dysphagia associated
cough 1 (0.8) -
wheeze --
difficulty in
breathing
4 (3.3) -
chest tightness --
inhaler use --
Belching associated
cough 2 (1.7) -
wheeze 2 (1.7) -
difficulty in
breathing
11 (9.2) 1 (1.2)
chest tightness 12 (10) 1 (1.2)
inhaler use 3 (2.5) -
*All values are given as number (percentage).
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severity and GORD is mixed. While Field et al. [20]
reported that asthma symptom severity in the week pre-
ceding their interview did not correlate with either
heartburn or regurgitation, the majority of studies have
shown a positive correlation [4-6,33]. The severity of
asthma in our patients (as defined by ATS criteria)
showed a strong and dose-dependent association with
GORD symptoms, an association that was independent
of known confounders for GORD. The association
between asthma severity and GORD symptoms has not
been described previously in the South Asian region.
As this study was a cross-sectional, there is no indica-
tion of a temporal sequence or causal relationship
between these two conditions. Whether the finding that
more severe forms of asthma were associated with more
reflux symptoms was due to reflux aggravating asthma
or severe bronchospasm promoting reflux could not be
determined.
In the present study, 36% of the asthmatics experi-
enced reflux-associated respiratory symptoms (RARS)
and these occurred more frequently in subjects who had
positive GORD symptom scores. Other studies have
investigated the association between typical GORD
symptoms and respiratory symptoms. Field et al.
reported a prevalence of 41.2%. In this study 45 asth-
matics out of 109 reported at least one RA0RS [20].
Another study reported that ‘moderately bothersome’
heartburn and acid regurgitation were significantly asso-
ciated with asthma symptoms (odds ratio = 3.2; 95%
confidence interval = 1.6-6.4), wheeze (OR = 3.5; 95%
CI = 1.7-7.2), and nocturnal cough (OR = 4.3; 95% CI =
2.1-8.7) independently of body mass index. This is the
first report of an association of RARS with atypical
symptoms of GORD.
Bronchodilator medication may predispose to gastro-
oesophageal reflux: theophylline has been shown to sti-
mulate gastric acid secretion and lower LOS pressure,
oral beta adrenergic agonists have been implicated in
lowering the LOS pressure [10,34], and oral corticoster-
oids have been shown to increase oesophageal acid con-
tact times [11]. Debley et al. [35] demonstrated that
GORD symptoms were associated with the use of
asthma medication. A number of studies contradict
these findings. Sontag et al. [36] showed that there was
no significant difference in reflux patterns in asthmatics
who were taking anti-asthmatic drugs versus those not
taking them. Field et al. [20] noted that none of the
asthma medications were associated with an increased
likelihood of having symptoms of GORD. The Nord-
Trondelag health survey showed that asthmatics had
reflux symptoms to a 60% greater extent than non-asth-
matics. However, asthma nor the use of asthma medica-
tion influenced the risk of GORD [37]. We found that
64.4% of our asthmatics used one more oral drugs
(beta2 agonists, xanthines or steroids) for control of
asthma. Asthmatics with positive GORD symptoms
scores had significantly higher usage of oral salbutamol
on univariate analysis. However adjustment for oral sal-
butamol use alone, and subsequently for all five asthma
medications did not substantially alter the risk estimates
for the different categories of asthma severity. Thus we
have demonstrated that use of asthma medication, oral
or otherwise, does not seem to influence the presence
or absence of GORD. This has not been previously
reported in an Asian population.
Several factors are known to contribute to both
GORD and asthma. To reduce the risk of confounding
factors we adjusted statistically for all plausible confoun-
ders. Alcohol consumption and smoking are known to
be associated with GORD [38]. Recent reports indicate
that in Sri Lanka, 41% of males and 3.4% of females are
current smokers and 23% of men and 0.9% of women
take alcohol at least monthly [39]. In our study, the per-
centage of current smokers (20%) and drinkers (13.3%)
was lower than this. This could have been because these
patients were hospital clinic attendees who are regularly
exposed to health advice. The low prevalence may have
resulted in our failing to show an influence of these fac-
tors on the presence of GORD symptoms in asthmatics,
though it may also represent something specific about
asthmatics and GORD and warrant further investigation.
Increased body weight [40], increasing age and male sex
[41] are also known to be associated with GORD. Our
study design was such that asthmatics and controls were
comparable in age and sex. An asthmatic had a higher
risk of being GORD symptom positive compared to a
non-asthmatic even after adjustment for known con-
founders. This indicates a lack of strong confounding by
these factors, even though there was a significant differ-
ence in BMI, alcohol and tobacco consumption among
the two groups. These findings are in agreement with
previous studies [36].
Conclusion
In summary, use of an interviewer administered GORD
questionnaire has shown a higher prevalence of GORD
symptoms and RARS in a cohort of adult Sri Lankan asth-
matics compared to non-asthmatics. The use of asthma
medication does not influence the presence or absence of
GORD though asthma severity shows a significant associa-
tion. There is a significant burden of RARS morbidity in
the region. We have now shown that the prevalence of
RARS is associated not only with typical symptoms but
also with atypical symptoms of GORD. This suggests that
reflux associated respiratory symptoms may benefit from
more rigorous investigation and, even when typical symp-
toms are absent, treatment of GORD may be indicated.
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Additional file 1: Table S1 - Asthma severity, asthma medication
use and GORD symptom status.
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